This past October, CancerCare held a roundtable discussion titled “Improving the Quality of Life for Lung Cancer Patients” at its national headquarters in New York City. Celebrated lung cancer advocates and key opinion leaders in lung cancer treatment held a dialogue and gave presentations reviewing the significance of patient-reported outcomes related to patients with lung cancer.
A recent survey conducted by CancerCare of more than 1,300 breast, colon, lung and prostate cancer patients diagnosed within the past five years found that the vast majority had not heard the term “clinical pathway”. Even after it was defined, fewer than half claimed to be familiar with the term.
Clinical trials are a vital part of advancing cancer research and discovering new treatments. However, many people with cancer are uncertain if clinical trials are right for them. Read on to learn about how clinical trials work, what the risks and benefits are, and the rights that all people participating in clinical trials hold.
With over 30,000 members of the cancer community in attendance, the American Society of Clinical Oncology (ASCO) Annual Meeting is one of the biggest events of the year for breakthroughs in cancer research. Our recap aims to give a quick glance at the meeting’s highlights.
If you’d like to take a deeper dive into ASCO, you can listen to our Connect Education Workshop series, “Your Guide to the Latest Cancer Research and Treatments,” which features updates from ASCO 2015.